We, therefore, sought to assess the correlation of LIMD1 expression with different subtypes of TILs in NSCLC, including CD4 T cells, CD8 T cells, B cells, NK cells, dendritic cells (DCs), macrophages, myeloid-derived suppressor cells (MDSCs), mast cells, neutrophil, eosinophils, cancer-associated fibroblasts, endothelial cells, common lymphoid and myeloid progenitors, and hematopoietic stem cells, using Spearman correlation test in TIMER2 portal. Here, LIMD1 is linked to cancer.